Montara Therapeutics has announced the appointment of Jeremy Grunstein as Chief Business Officer. He will lead the company's strategic initiatives to combine its candidate MT1110 with other CNS-targeted drugs.
Who to call at Montara Therapeutics, and when
A new leader at Montara Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Montara Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Montara Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Montara Therapeutics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Montara Therapeutics
Location
135 Mississippi St
San Francisco, California, United States
About
Montara Therapeutics is a San Francisco–based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory Board (SAB). We bring a new approach to tackling challenging established targets, along with unique experience in developing enzyme activators and domain expertise in mitophagy. Our mission is to create innovative therapies for diseases of the CNS, with a focus on precision medicine and genetically validated targets to enhance drug safety and efficacy.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Montara Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
San FranciscoBiotechnology